Medical Device Firm iTraumaCare Names Combat Medical Systems Exclusive Distributor for Military Market in US

[San Antonio, Texas]  iTraumaCare, an early-stage medical device firm focused on developing traumatic injury solutions for first responder and military medicine applications, has selected Combat Medical Systems as its US Military distributor. Combat Medical Systems will spearhead sales and distribution of iTraumaCare’s iTClampTM Hemorrhage Control System to various branches of the US Military and Federal Government.

“The iTClamp fills the gap that currently exists in the Care Under Fire phase of tactical medicine. It’s intuitive and easily applied, and its impact on the challenges we face in hemorrhage control is significant,” said Corey Russ, President, Combat Medical Systems.

iTraumaCare’s CEO and founder, Dr. Dennis Filips, said, “We selected Combat Medical Systems as our exclusive US Military distributor due to their extensive depth of experience and proven track record in working with the US military.”

The iTClamp is designed to control severe bleeding – a leading cause of death in traumatic injury – in seconds.  The iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. It is available in the US, European Union and Canada.

Combat Medical Systems, founded by a team of military medical personnel and industry specialists, has a straightforward goal: simplify tactical medicine and decrease pre-hospital mortality. Combat Medical Systems is located outside Fort Bragg, N.C., which strategically positions the company to stay current on military medical trends.

Incorporated in 2010 and based in Edmonton, Canada with its global commercialization headquarters in San Antonio, Texas, iTraumaCare is addressing unmet needs in the field of emergency medicine by developing, manufacturing, and commercializing solutions to treat common causes of preventable death in traumatic injury scenarios.


Vidacare Corporation launches the T.A.L.O.N. Intraosseous Vascular Access System

[San Antonio, Texas] At the 2013 Military Health System Research Symposium (MHSRS) in Fort Lauderdale, Vidacare Corporation will be launching the T.A.L.O.N.TM (Tactically Advanced Lifesaving Intraosseous Needle) Intraosseous Vascular Access System for military use.

The T.A.L.O.N. system is a groundbreaking single needle solution for vascular access that provides combat life savers and medics with rapid and accurate manual IO access to seven FDA cleared  IO sites – proximal tibia (below the knee), distal tibia (ankle), proximal humerus (shoulder) and the sternum.  The T.A.L.O.N. system is the first IO system to meet all Committee on Tactical Casualty Care (CoTCCC) recommendations for IO devices.

T.A.L.O.N. provides rapid vascular access through the intraosseous (inside the bone) space and helps deliver vital fluids and drugs through this space, the body’s largest non-collapsible vein, to injured soldiers safely and quickly.  T.A.L.O.N. is a non-powered vascular access option that complements Vidacare’s powered EZ-IO® Intraosseous Vascular Access System that is widely utilized in combat medicine today.

This system is designed to provide battlefield responders a tactical advantage needed in the combat zone via its lightweight and minimal cube design, proven ability to gain vascular access quickly and safely, and its versatility because no additional intraosseous vascular access gear or tools are needed.  As with any vascular access site, the IO insertion site should be monitored frequently and the system should be used only when anatomical landmarks can be clearly identified and in accordance with the T.A.L.O.N. system’s instructions for use.

The T.A.L.O.N. system will be commercially available in the United States starting in early Q4 2013.

“This system is designed specifically to address the needs and concerns of military personnel treating patients under strenuous conditions.  The T.A.L.O.N. system will help achieve vascular access and save lives when seconds count also its design is ideal for the combat zone,” said Mark Mellin, President and CEO of Vidacare Corporation.

T.A.L.O.N. will be sold to the military market through an exclusive relationship with Combat Medical Systems.

“The 7-site access achievable with T.A.L.O.N. will give medical responders a distinct life-saving advantage during casualty resuscitation. We are excited to launch this device with Vidacare, and we are certain it will have an immediate positive impact in tactical medicine,” said Corey Russ, President, Combat Medical Systems.

Established in 2001, Vidacare Corporation is the pioneer of a broad technology platform for accessing the intraosseous (inside the bone) space. Current products include the EZ-IO® Intraosseous Vascular Access System and the OnControl® Bone Access System.  Applications include vascular access, emergency and disaster medicine, oncology and spinal surgery. Vidacare’s focus is on enhancing clinical efficacy, patient safety and comfort, and reducing complications and their associated costs, has resulted in its devices becoming the recognized technology standard. Privately held, the company is based in San Antonio, Texas, and its products are marketed in over 50 countries worldwide.

Combat Medical Systems was founded in 2008 by a team of experienced military medical personnel and industry product specialists with a mission to simplify tactical medicine. Headquartered in Fayetteville, N.C., nearby Ft. Bragg acts as its catalyst to staying current with medical trends and product development. (